Polymun(其他國家)

Polymun

奧地利Polymunwww.polymun.comPolymun是一家CRO企業(yè)，盈利用于投資新的產(chǎn)品線和技術(shù)平臺。核心技術(shù)是哺乳動物和微生物細(xì)胞表達(dá)技術(shù)。中和型HIV-1抗體最有特色，四個克隆C2F5，C2G12，C4E10，b12已在世界范圍內(nèi)作為金標(biāo)準(zhǔn)。另有HIV-1抗原和蛋白，重組人和豬的胰酶，過氧化物歧化酶等。Polymunwasfoundedin1992byProf.HermannKa tinger.ItisaprivatecompanyfullyownedbytheKatingerfamily.Revenuesaregeneratedbycontractdevelopmentandmanufacturingaswellascreatingliposomalformatsofdrugsforcontractpartners.Theserevenuesareinvestedintheproprietaryproductpipelineandthefurtherdevelopmentoftechnologyplatforms.TheR&Dprojectsandtechnologiesareopenforco-developmentandlicensing.PolymunoperatesinaccordancewithcurrentGMPguidelinesandholdsanAustrianproductionlicenseforpharmaceuticals(§63AustrianPharmaceuticalLaw)thusmeetingtheEUrequirementsfordrugmanufacturing.ThelastinspectionhastakenplaceinSeptember2008.Competence&ServicesThecorecompetenceofPolymunisthedevelopme